74 related articles for article (PubMed ID: 1768841)
1. Hexadecylphosphocholine: determination of serum concentrations in rats.
Unger C; Fleer E; Damenz W; Hilgard P; Nagel G; Eibl H
J Lipid Mediat; 1991; 3(1):71-8. PubMed ID: 1768841
[TBL] [Abstract][Full Text] [Related]
2. Hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine: a comparison of hemolytic activity, serum binding and tissue distribution.
Kötting J; Marschner NW; Neumüller W; Unger C; Eibl H
Prog Exp Tumor Res; 1992; 34():131-42. PubMed ID: 1438796
[No Abstract] [Full Text] [Related]
3. Distribution of hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine in rat tissues during steady-state treatment.
Marschner N; Kötting J; Eibl H; Unger C
Cancer Chemother Pharmacol; 1992; 31(1):18-22. PubMed ID: 1458555
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of erucylphosphocholine on brain tumor cells in vitro and in vivo.
Erdlenbruch B; Jendrossek V; Marx M; Hunold A; Eibl H; Lakomek M
Anticancer Res; 1998; 18(4A):2551-7. PubMed ID: 9703909
[TBL] [Abstract][Full Text] [Related]
5. Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug release.
Lindner LH; Hossann M; Vogeser M; Teichert N; Wachholz K; Eibl H; Hiddemann W; Issels RD
J Control Release; 2008 Jan; 125(2):112-20. PubMed ID: 18022271
[TBL] [Abstract][Full Text] [Related]
6. Systemic administration of alkylphosphocholines. Erucylphosphocholine and liposomal hexadecylphosphocholine.
Kaufmann-Kolle P; Berger MR; Unger C; Eibl H
Adv Exp Med Biol; 1996; 416():165-8. PubMed ID: 9131143
[No Abstract] [Full Text] [Related]
7. High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2.
Zhang Y; Hua Y; Benbrook DM; Covey JM; Dai G; Liu Z; Chan KK
Cancer Chemother Pharmacol; 2006 Nov; 58(5):561-9. PubMed ID: 16534614
[TBL] [Abstract][Full Text] [Related]
8. Determination of vinflunine in rat plasma by liquid chromatography-electrospray ionization mass spectrometry for a pharmacokinetic study.
Zhao X; Liu X; Wang Y; Zhong J; Chen Y; Wang G
J Pharm Biomed Anal; 2006 Jun; 41(3):906-11. PubMed ID: 16460899
[TBL] [Abstract][Full Text] [Related]
9. Determination of ferrocene-A in the blood serum of rabbits using reversed-phase microcolumn HPLC.
Pochkhidze MSh; Asatiani LP; Rukhadze MD; Chitiashvili ZJ; Tsartsidze MA
Biomed Chromatogr; 1999 Feb; 13(1):89-91. PubMed ID: 10191953
[TBL] [Abstract][Full Text] [Related]
10. Highly sensitive analysis of the anti-tumor agent 1-[4-(furo[2,3-b]-quinolin-4-ylamino)phenyl]ethanone in rat plasma by high-performance liquid chromatography using electrochemical detection.
Huang YB; Wu PC; Hsu MW; Chen YL; Tzeng CC; Tsai YH
J Pharm Biomed Anal; 2005 Jul; 38(3):551-5. PubMed ID: 15925259
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the tissue distribution of hexadecylphosphocholine and erucylphosphocholine.
Reitz RC; Kötting J; Unger C; Eibl H
Prog Exp Tumor Res; 1992; 34():143-52. PubMed ID: 1438797
[No Abstract] [Full Text] [Related]
12. Alkylphosphocholines: influence of structural variation on biodistribution at antineoplastically active concentrations.
Kötting J; Berger MR; Unger C; Eibl H
Cancer Chemother Pharmacol; 1992; 30(2):105-12. PubMed ID: 1600590
[TBL] [Abstract][Full Text] [Related]
13. Quantitative determination of DRF-1042 in human plasma by HPLC: validation and application in clinical pharmacokinetics.
Upreti VV; Mamidi RN; Katneni K; Srinivas NR
Biomed Chromatogr; 2003 Sep; 17(6):385-90. PubMed ID: 13680849
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic behavior and antineoplastic activity of liposomal hexadecylphosphocholine.
Kaufmann-Kolle P; Drevs J; Berger MR; Kötting J; Marschner N; Unger C; Eibl H
Cancer Chemother Pharmacol; 1994; 34(5):393-8. PubMed ID: 8070005
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships of alkylphosphocholine derivatives: antineoplastic action on brain tumor cell lines in vitro.
Jendrossek V; Hammersen K; Erdlenbruch B; Kugler W; Krügener R; Eibl H; Lakomek M
Cancer Chemother Pharmacol; 2002 Jul; 50(1):71-9. PubMed ID: 12111115
[TBL] [Abstract][Full Text] [Related]
16. Quantitative determination of zidovudine diaryl phosphate triester pro-drugs in rat plasma by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
Zhu M; Xie B; Tang G; Hu A; Fang M; Wu Z; Zhao Y
J Pharm Biomed Anal; 2008 Dec; 48(5):1417-24. PubMed ID: 19118970
[TBL] [Abstract][Full Text] [Related]
17. Fast and sensitive liquid chromatography/electrospray mass spectrometry method to study ocular penetration of EDL-155, a novel antitumor agent for retinoblastoma in rats.
Ramagiri S; Ma F; Kosanam H; Wang X; Patil R; Miller DD; Geisert E; Yates CR
J Mass Spectrom; 2009 May; 44(5):786-93. PubMed ID: 19160451
[TBL] [Abstract][Full Text] [Related]
18. Determination of bound sulfur in serum by gas dialysis/high-performance liquid chromatography.
Ogasawara Y; Ishii K; Togawa T; Tanabe S
Anal Biochem; 1993 Nov; 215(1):73-81. PubMed ID: 8297017
[TBL] [Abstract][Full Text] [Related]
19. Determination of anti-tumor agent bis(p-fluorobenzyl)trisulfide and its degraded compound in rat blood using reversed phase high-performance liquid chromatography.
Gu L; Li L; Chen Z; Pan H; Jiang H; Zeng S; Xu X; An H
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 868(1-2):77-82. PubMed ID: 18479981
[TBL] [Abstract][Full Text] [Related]
20. In vitro investigations on the antineoplastic effect of hexadecylphosphocholine.
Yanapirut P; Berger MR; Reinhardt M; Schmähl D
Arzneimittelforschung; 1991 Jun; 41(6):652-5. PubMed ID: 1930356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
